Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, Inc.: A US-based company innovating in drug discovery, development, and commercialization.
Founded
1998Ironwood Pharmaceuticals, Inc.: A US-based company innovating in drug discovery, development, and commercialization.
Founded in Cambridge, Massachusetts, Ironwood Pharmaceuticals, Inc. is dedicated to the discovery, development, manufacturing, and commercialization of innovative drugs. The company's core mission is to provide effective treatments for gastrointestinal, cardiovascular, and other chronic diseases. Ironwood's product portfolio includes treatments for conditions such as cholesterol management, gastrointestinal disorders, pain, and inflammation. Their market focus is on addressing unmet medical needs and improving patient quality of life through advanced pharmaceutical solutions.
Ironwood Pharmaceuticals has garnered attention through its participation in major healthcare conferences such as the Jefferies Global Healthcare Conference and Digestive Disease Week®. Notable achievements include the development of Apraglutide for Short Bowel Syndrome with Intestinal Failure (SBS-IF). The company's impact is underscored by its commitment to advancing medical science and delivering therapeutic solutions that address significant health challenges.
Companies similar to Ironwood Pharmaceuticals include Salix Pharmaceuticals, Intercept Pharmaceuticals, SpringWorks Therapeutics and Tioga Pharmaceuticals.
Ironwood Pharmaceuticals was founded in 1998.
Ironwood Pharmaceuticals' headquarters is located in Boston, MA, US.
Ironwood Pharmaceuticals' most recent funding round was for $150M (USD) in September 2016.
As of Sep 26, 2016, Ironwood Pharmaceuticals has disclosed funding of $634M (USD). Undisclosed round amounts are excluded.
Ironwood Pharmaceuticals has 219 employees as of Feb 6, 2024.
Tioga Pharmaceuticals
